BRAF/MEK and PD-1 Inhibition Tied to Better Overall Survival in Advanced Melanoma

BRAF/MEK and PD-1 inhibition significantly improves overall survival compared with other treatments for patients with advanced BRAF-mutated melanoma, Canada-based researchers say.
Reuters Health Information

http://ift.tt/2eeJTKe